Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score Development

Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score Development

OBJECTIVE: Most patients with rheumatoid arthritis (RA) strive to consolidate their treatment from methotrexate combinations. The objective of this analysis was to identify patients with RA most likely to achieve remission with tocilizumab (TCZ) monotherapy by developing and validating a prediction...

Full description

Bibliographic Details
Main Authors: Collins, Jamie E. (Author), Johansson, Fredrik D. (Author), Gale, Sara (Author), Kim, Seoyoung (Author), Shrestha, Swastina (Author), Sontag, David Alexander (Author), Stratton, Jacklyn (Author), Trinh, Huong (Author), Xu, Chang (Author), Losina, Elena (Author), Solomon, Daniel H. (Author)
Other Authors: Massachusetts Institute of Technology. Institute for Medical Engineering & Science (Contributor)
Format: Article
Language:English
Published: Wiley, 2021-04-13T19:44:01Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items